Eli Lilly Acquires Centessa Pharmaceuticals to Enhance Treatment Options for Sleep Disorders#United_States#Indianapolis#Eli_Lilly#Narcolepsy#Centessa_Pharmaceuticals
Eli Lilly Acquires Centessa Pharmaceuticals to Enhance Treatment Options for Sleep Disorders
Eli Lilly has successfully acquired Centessa Pharmaceuticals to advance new treatments for sleep-wake disorders, notably narcolepsy. This acquisition aims to leverage orexin receptor 2 agonists in addressing unmet medical needs.
third-news.com
June 24, 2026 at 1:24 PM
Eli Lilly Acquires Centessa Pharmaceuticals to Enhance Treatment Options for Sleep Disorders#United_States#Indianapolis#Eli_Lilly#Narcolepsy#Centessa_Pharmaceuticals
Concerns Over Shareholder Rights in Recent Corporate Sales of SEM, UNF, CNTA, and ASRT#USA#New_York#Select_Medical#UniFirst#Centessa_Pharmaceuticals
Concerns Over Shareholder Rights in Recent Corporate Sales of SEM, UNF, CNTA, and ASRT
Investor rights attorney firm Halper Sadeh LLC is probing potential violations by Select Medical, UniFirst, Centessa Pharmaceuticals, and Assertio Holdings regarding shareholder transactions and fiduciary duties.
third-news.com
May 19, 2026 at 10:37 PM
Concerns Over Shareholder Rights in Recent Corporate Sales of SEM, UNF, CNTA, and ASRT#USA#New_York#Select_Medical#UniFirst#Centessa_Pharmaceuticals
Monteverde & Associates Launches Investigation into Centessa Pharmaceuticals' Proposed Sale to Eli Lilly#United_States#New_York#Eli_Lilly#Juan_Monteverde#Centessa_Pharmaceuticals
Monteverde & Associates Launches Investigation into Centessa Pharmaceuticals' Proposed Sale to Eli Lilly
Class action firm Monteverde & Associates is investigating Centessa Pharmaceuticals regarding its proposed sale to Eli Lilly. What does this mean for shareholders?
third-news.com
April 1, 2026 at 8:35 PM
Monteverde & Associates Launches Investigation into Centessa Pharmaceuticals' Proposed Sale to Eli Lilly#United_States#New_York#Eli_Lilly#Juan_Monteverde#Centessa_Pharmaceuticals
Investigation Launched into Centessa Pharmaceuticals' Fairness in Shareholder Transaction#United_States#Milwaukee#Ademi_LLP#Fair_Price#Centessa_Pharmaceuticals
Investigation Launched into Centessa Pharmaceuticals' Fairness in Shareholder Transaction
Ademi LLP is probing Centessa Pharmaceuticals for potential fiduciary violations in a recent transaction. Shareholders' rights are at stake.
third-news.com
March 31, 2026 at 5:52 PM
Investigation Launched into Centessa Pharmaceuticals' Fairness in Shareholder Transaction#United_States#Milwaukee#Ademi_LLP#Fair_Price#Centessa_Pharmaceuticals
Investigation into APLS, CNTA, and BIRD: Are They Minimizing Shareholder Rights?#USA#New_York#Allbirds#Centessa_Pharmaceuticals#Apellis_Pharmaceuticals
Investigation into APLS, CNTA, and BIRD: Are They Minimizing Shareholder Rights?
Halper Sadeh LLC examines potential violations by Apellis Pharmaceuticals, Centessa Pharmaceuticals, and Allbirds, questioning the fairness of recent deals and their impacts on shareholders.
third-news.com
March 31, 2026 at 5:17 PM
Investigation into APLS, CNTA, and BIRD: Are They Minimizing Shareholder Rights?#USA#New_York#Allbirds#Centessa_Pharmaceuticals#Apellis_Pharmaceuticals
Eli Lilly Expands Neuroscience Portfolio with Centessa Pharmaceuticals Acquisition#USA#Indianapolis#Eli_Lilly#Centessa_Pharmaceuticals#OX2R_agonists
Eli Lilly Expands Neuroscience Portfolio with Centessa Pharmaceuticals Acquisition
Eli Lilly and Company is set to acquire Centessa Pharmaceuticals, focusing on advancing treatments for sleep-wake disorders. This strategic move promises to enhance Lilly's neuroscience capabilities.
third-news.com
March 31, 2026 at 10:57 AM
Eli Lilly Expands Neuroscience Portfolio with Centessa Pharmaceuticals Acquisition#USA#Indianapolis#Eli_Lilly#Centessa_Pharmaceuticals#OX2R_agonists